摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

11-(ethoxycarbonyl)-2-azatricyclo<5.3.1.03,8>undecan-9-one | 141584-12-5

中文名称
——
中文别名
——
英文名称
11-(ethoxycarbonyl)-2-azatricyclo<5.3.1.03,8>undecan-9-one
英文别名
11-(ethoxycarbonyl)-2-azatricyclo<5.3.1.03,8>undecan-9-one;11-(ethoxycarbonyl)-2-azatricyclo[5.3.1.03,8]undecan-9-one
11-(ethoxycarbonyl)-2-azatricyclo<5.3.1.03,8>undecan-9-one化学式
CAS
141584-12-5
化学式
C13H19NO3
mdl
——
分子量
237.299
InChiKey
YISMNLBTOFSKEE-AMOVGVPESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    17.0
  • 可旋转键数:
    2.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.85
  • 拓扑面积:
    55.4
  • 氢给体数:
    1.0
  • 氢受体数:
    4.0

反应信息

  • 作为反应物:
    描述:
    11-(ethoxycarbonyl)-2-azatricyclo<5.3.1.03,8>undecan-9-one二异丙胺lithium diisopropyl amide 作用下, 以 四氢呋喃 为溶剂, 反应 4.0h, 以80%的产率得到5α,6,7,8,9α,10α-hexahydro-5-<1-(ethoxycarbonyl)methyl>-4-quinolone
    参考文献:
    名称:
    An intramolecular Diels-Alder/retro-Mannich approach to the cis-perhydroquinoline ring system. Model studies toward the synthesis of Lycopodium alkaloids
    摘要:
    Model studies toward the preparation of cis-decahydroquinoline derivatives using an IMDA/retro-Mannich strategy were carried out. Tricyclic amino ester 13, prepared via an IMDA reaction of 1,2-dihydropyridine 11, was ring-opened on treatment with excess LDA. Trapping the intermediate dianion 17 with TMSCl gave the polysilylated derivatives 18. Subsequent N-acylation with benzyl chloroformate provided ene carbamate 19, which on catalytic hydrogenation gave the desired decahydroquinoline 21. In a similar manner, 1,2-dihydropyridine 22 was cyclized and ring-opened in two steps to give the desired cis-hexahydroquinolone 25. N-Acylation of 25 with LDA and benzyl chloroformate provided the benzyl carbamate 26 in quantitative yield. The target model compounds, 21 and 26, were prepared with complete control of relative stereochemistry at their three contiguous stereogenic centers. The mechanisms for the retro-Mannich ring-openings are discussed.
    DOI:
    10.1021/jo00041a011
  • 作为产物:
    参考文献:
    名称:
    An intramolecular Diels-Alder/retro-Mannich approach to the cis-perhydroquinoline ring system. Model studies toward the synthesis of Lycopodium alkaloids
    摘要:
    Model studies toward the preparation of cis-decahydroquinoline derivatives using an IMDA/retro-Mannich strategy were carried out. Tricyclic amino ester 13, prepared via an IMDA reaction of 1,2-dihydropyridine 11, was ring-opened on treatment with excess LDA. Trapping the intermediate dianion 17 with TMSCl gave the polysilylated derivatives 18. Subsequent N-acylation with benzyl chloroformate provided ene carbamate 19, which on catalytic hydrogenation gave the desired decahydroquinoline 21. In a similar manner, 1,2-dihydropyridine 22 was cyclized and ring-opened in two steps to give the desired cis-hexahydroquinolone 25. N-Acylation of 25 with LDA and benzyl chloroformate provided the benzyl carbamate 26 in quantitative yield. The target model compounds, 21 and 26, were prepared with complete control of relative stereochemistry at their three contiguous stereogenic centers. The mechanisms for the retro-Mannich ring-openings are discussed.
    DOI:
    10.1021/jo00041a011
点击查看最新优质反应信息

同类化合物

锯齿石松宁 脱氧卡色素B 箭毒蛙毒素 C 环戊二烯并[b]吖庚英-5-醇,十氢- 坎库碘铵 十氢喹啉 十氢-2-甲基喹啉 八氢对苯二酚-4(1H)-酮 八氢喹啉-2(1H)-酮 八氢-2,6-喹啉二酮 二氯化硅2,3-萘醛菁 β-羟基丙基-环糊精 [(4aS,4bR,6aS,8S,10aS,10bS,12aS)-10a,12a-二甲基-1,2,3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-十六氢萘并[6,5-f]喹啉-8-基]2-[4-[二(2-氯乙基)氨基]苯基]乙酸酯 [(4aS,4bR,6aS,8S,10aS,10bS,12aS)-1,10a,12a-三甲基-2-氧代-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-十四氢萘并[6,5-f]喹啉-8-基]2-[4-[二(2-氯乙基)氨基]苯基]乙酸酯 8H-13,3,6a-乙基亚基-7,10-亚甲基噁庚并[3,4-i]-1-苯并吖辛因-8-酮,1-乙基十四氢-12a-羟基-6-甲氧基-3-甲基-,(3R,6S,6aS,7R,7aS,10S,12aS,13S,13aR,15R)-(9CI) 8-羟基-十氢喹啉 4-乙炔基-2-甲基十氢喹啉-4-醇 4-乙炔基-2-甲基-1-(3-苯丙-2-炔-1-基)十氢喹啉-4-醇 3-羟基-13,17-开环-5-雄甾烯-17-酸-13,17-内酰胺(4-(二(2-氯乙基)氨基)苯基)丁酸酯 3-甲氧基-17-氮杂-高雄甾-5-烯-17-酮 2H-环戊二烯并[b]吡啶-2-酮,八氢-4-甲基-,[4S-(4-α-,4a-bta-,7a-bta-)]-(9CI) 2-甲基-1-(3-丙氧基-丙基)-八氢-喹啉-4-酮 2,5-二丙基十氢喹啉 1-(3-甲氧基-丙基)-2-甲基-八氢-喹啉-4-酮 1-(3-氯-丙基)-十氢-喹啉 1-(3-乙氧基-丙基)-2-甲基-十氢-喹啉 1-(3-乙氧基-丙基)-2-甲基-八氢-喹啉-4-酮 1,2,2-三甲基-八氢-喹啉-4-酮 (4aS,4bR,8S,10aR,10bS,12aS)-10a,12a-二甲基-2-羰基-1,2,3,4,4a,4b,5,7,8,9,10,10a,10b,11,12,12a-十六氢萘并[2,1-f]喹啉-8-基{4-[二(2-氯乙基)氨基]苯基}乙酸酯 (4aS,4bR,6aS,8S,10aS,10bS,12aS)-8-羟基-10a,12a-二甲基-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-十四氢-1H-萘并[2,1-f]喹啉-2-酮 (3S,13R)-1,2,3,4,4aalpha,5,11,11aalpha-八氢-2,2,5-三甲基-3beta,5beta-乙桥-10bH-吡啶并[3,2-b]咔唑-10bbeta,13-二醇 (3R,6S,6aS,7R,7aS,10S,12aS,13R,13aR,14S,15R)-1-乙基十四氢-12a,14-二羟基-6-甲氧基-3-甲基-8H-13,3,6a-亚乙基-7,10-甲桥氧杂卓并[3,4-i]-1-苯并氮杂环辛四烯-8-酮 (2S,4aR,8aR)-2-甲基八氢-4(1H)-喹啉酮 (2R,4R,4As,8As)-rel-4-乙炔基十氢-1,2-二甲基-4-喹啉醇 1-(2-Cyclopentylethyl)-perhydrochinolin Perhydrodibenzochinolizin octahydroquinoline-1(2H)-carbonitrile N-Acetylbaikeidin 4-[4-[(4aR,8aR)-3,4,4a,5,6,7,8,8a-octahydro-2H-quinoline-1-carbonyl]thiophen-2-yl]piperidine-1-carboxamide N-Chlor-trans-decahydrochinolin (4aR,8aR)-1-{4-[4-(octahydro-quinoline-1(2H)-ylcarbonyl)-thiophen-2-yl]-piperidin-1-yl}-ethanone (7-Acetyl-3a,6-dimethyl-3-oxo-tetradecahydro-7-aza-cyclohepta[e]inden-6-yl)-acetic acid 6,7-Cyclobutano-1,2-cyclopropano-chinolizidin 2-Methyl-2,3-tetramethylen-N-cyanoaziridin (4aR)-2-oxo-1-[(1R)-1-phenylethyl]-4,5,6,7-tetrahydro-3H-quinoline-4a-carboxylic acid (4aR,8aR)-(octahydro-quinolin-1(2H)-yl)-(5-piperidin-4-yl-thiophen-3-yl)-methanone 5-(octahydroquinolin-1-yl)-5-oxopentanoic acid N-benzyl-N-isopropylamide 3,4,4-Trimethyl-2-azabicyclo<3.3.0>octan (4aR,8aR)-4-[4-(octahydro-quinoline-1(2H)-ylcarbonyl)-thiophen-2-yl]-piperidine-1-carboxylic acid tert-butyl ester 1-Aza-4,11-dioxo-3-oxo-methoxycarbonyl-tricyclo<5.3.1.05,10>undecan